Novanta - NOVT Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NOVT shares.
View NOVT analyst ratings or view top-rated stocks.

Novanta's stock was trading at $176.33 at the beginning of the year. Since then, NOVT shares have decreased by 31.9% and is now trading at $120.14.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our NOVT earnings forecast.

Novanta Inc. (NASDAQ:NOVT) issued its quarterly earnings data on Tuesday, August, 9th. The technology company reported $0.78 EPS for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. The technology company had revenue of $215.36 million for the quarter, compared to analyst estimates of $209.07 million. Novanta had a net margin of 7.99% and a trailing twelve-month return on equity of 20.14%. The firm's revenue was up 28.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.62 earnings per share.

Novanta updated its third quarter 2022 earnings guidance on Tuesday, September, 13th. The company provided earnings per share (EPS) guidance of $0.71-$0.76 for the period, compared to the consensus estimate of $0.77. The company issued revenue guidance of $214.00 million-$216.00 million, compared to the consensus revenue estimate of $212.96 million.

44 employees have rated Novanta Chief Executive Officer Matthijs Glastra on Glassdoor.com. Matthijs Glastra has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Novanta investors own include NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Intuitive Surgical (ISRG), Lam Research (LRCX), Altria Group (MO), AT&T (T), Abiomed (ABMD), Advanced Micro Devices (AMD) and Broadcom (AVGO).

Novanta trades on the NASDAQ under the ticker symbol "NOVT."

Novanta's stock is owned by many different retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (5.86%), Conestoga Capital Advisors LLC (4.00%), Artisan Partners Limited Partnership (2.83%), Allspring Global Investments Holdings LLC (2.78%), William Blair Investment Management LLC (2.75%) and JPMorgan Chase & Co. (2.56%). Insiders that own company stock include Brian S Young, Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad.
View institutional ownership trends.

Shares of NOVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NOVT stock can currently be purchased for approximately $120.14.

Novanta (NASDAQ:NOVT) has a market capitalization of $4.28 billion and generates $706.79 million in revenue each year. The technology company earns $50.33 million in net income (profit) each year or $1.78 on an earnings per share basis.

The company employs 2,700 workers across the globe.

Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The official website for the company is www.novanta.com. The technology company can be reached via phone at (781) 266-5700, via email at investorrelations@novanta.com, or via fax at 781-266-5114.